Welcome to our dedicated page for Teradyne SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Teradyne, Inc. (NASDAQ: TER) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. Teradyne is incorporated in Massachusetts and lists its common stock on the Nasdaq Stock Market LLC under the symbol TER. As a public issuer, it files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents. These filings offer detailed information about Teradyne’s automated test equipment and advanced robotics businesses, financial condition, governance, and material corporate events.
Recent Form 8-K filings illustrate the range of topics covered in Teradyne’s current reports. The company files 8-Ks to furnish quarterly earnings press releases under Item 2.02, disclosing results for segments such as Semiconductor Test, Product Test, and Robotics. Other 8-Ks report on executive officer changes, including the appointment of a new Chief Financial Officer, and provide summaries of related compensation and change-of-control arrangements under Item 5.02. Teradyne also uses Form 8-K to disclose director appointments, committee assignments, and amendments to its Amended and Restated By-Laws, including changes to shareholder proposal and director nomination procedures.
Filings related to governance, such as bylaw amendments, describe how Teradyne manages shareholder rights, nomination windows, voting standards, and meeting procedures. These documents help investors understand the company’s corporate governance framework. Additional filings may address material modifications to the rights of security holders, such as changes linked to bylaw updates, and provide timelines for shareholder actions ahead of annual meetings.
On Stock Titan, Teradyne’s SEC filings are presented with AI-powered summaries designed to make complex regulatory documents more accessible. Annual reports (Form 10-K) and quarterly reports (Form 10-Q) can be reviewed with AI-generated highlights that point to key discussions of segment performance, risk factors, and liquidity. Current reports (Form 8-K) are summarized to emphasize the nature of each material event, whether it involves financial results, leadership changes, or governance updates. Investors can also track insider-related filings such as Form 4, where available, to monitor transactions by directors and executive officers. Real-time updates from EDGAR and AI explanations allow users to quickly identify the most relevant information in Teradyne’s filings without reading every page in full.
Teradyne, Inc. director Peter Herweck acquired 92 shares of Common Stock through a compensation-related award. The transaction reflects his deferral of quarterly cash fees into deferred stock units, which convert one-for-one into Common Stock. Following this grant, he directly holds 15,466 shares. The deferred stock units are generally settled within ninety days after he no longer serves as a non-employee director.
Teradyne director Paul J. Tufano increased his holdings through deferred stock compensation rather than open-market buying. He acquired 159 shares of Teradyne common stock on March 26, 2026 as a grant, bringing his direct ownership to 65,045 shares.
The footnote explains this represents a deferral of his quarterly cash compensation into deferred stock units, which are calculated using the closing share price on the issuance date. These deferred stock units are settled one-for-one in common stock, generally within ninety days after he no longer serves as a non-employee director.
Teradyne, Inc. director Henry Andrew Chisholm acquired 75 shares of Common Stock-equivalent deferred stock units (DSUs) as a grant linked to his quarterly cash compensation. The award was priced at $0 per share as it represents deferred fees rather than a market purchase.
Following this compensation-related acquisition, he directly holds 2,207 shares of Common Stock. According to the disclosure, DSUs are calculated using the closing stock price on the issuance date and are settled one-for-one in Common Stock, generally within ninety days after a non-employee director no longer serves on the board.
Teradyne Inc filing: amended Schedule 13G/A discloses that The Vanguard Group reports zero beneficial ownership of Teradyne common stock. The filing describes an internal realignment effective 01/12/2026 that led certain Vanguard subsidiaries and business divisions to report holdings separately; Vanguard states it no longer is deemed to beneficially own those securities.
The amendment is signed by Ashley Grim on 03/27/2026 and lists 0% ownership and 0 shares beneficially owned.
Teradyne, Inc. is asking shareholders to vote at its May 8, 2026 annual meeting on three items: electing nine directors, approving 2025 executive pay on an advisory basis, and ratifying PricewaterhouseCoopers as auditor for 2026.
The company reported 2025 revenue of $3.19 billion and highlighted growth in Semiconductor Test driven by AI applications, Product Test strength in defense and aerospace, and improving trends in Robotics. Executive pay is heavily performance-based, with 2025 cash incentives for key officers paying out at 136%–145% of target and performance-based RSUs tied to profit and relative total shareholder return.
The Board emphasizes strong governance, including an independent Chair, majority‑independent Board and committees, proxy access, anti‑hedging and pledging policies, mandatory Rule 10b5‑1 plans for insiders, and active shareholder engagement, with outreach to holders of about 70% of shares in 2025.
Teradyne, Inc. director Ernest E. Maddock recorded a small, routine equity-related change in his holdings. On March 13, 2026, he received 2 deferred stock units (DSUs) credited as dividends on existing DSUs, in lieu of cash. This transaction is classified as an exempt "other" acquisition under Exchange Act Rule 16b-3(d). Following this adjustment, he is credited with a total of 9,597 units tied to Teradyne common stock, which will generally be settled one-for-one in shares within ninety days after he no longer serves as a non-employee director.
TERADYNE, INC director Paul J. Tufano reported a small administrative change in his equity holdings. On March 13, 2026, he was credited with 25 deferred stock units (DSUs) in lieu of cash dividends on his existing DSUs, at no cash cost per unit. These DSUs are scheduled to be settled one-for-one in Teradyne common stock, generally within ninety days after he no longer serves as a non-employee director. Following this transaction, his directly held common stock and DSU-related position reported in the filing totals 64,886 shares, reflecting a routine, compensation-related adjustment rather than an open-market trade.
Teradyne director Peter Herweck reported a small routine equity adjustment tied to his board compensation. He received 5 deferred stock units, or DSUs, on March 13, 2026 as dividends paid on existing DSUs, taken in stock units instead of cash. These DSUs will convert into an equal number of Teradyne common shares, generally within ninety days after he no longer serves as a non-employee director. Following this transaction, his directly held common stock position reported in this filing is 15,374 shares, indicating this is a minor, non-market administrative change rather than an open-market trade.
Teradyne director Mercedes Johnson reported an open-market stock sale. On the stated date, Johnson sold 625 shares of Teradyne common stock at a price of $299.20 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 3, 2025.
After this transaction, Johnson directly owned 6,988 shares of common stock. An additional 1,876 shares were held indirectly by The Mercedes Johnson Trust UAD 07/23/04, for which Johnson is trustee and sole beneficiary.